Oragenics Inc. (OGEN)
AMEX: OGEN
· Real-Time Price · USD
4.58
-0.35 (-7.10%)
At close: Jun 12, 2025, 3:59 PM
4.56
-0.44%
After-hours: Jun 12, 2025, 07:51 PM EDT
Oragenics Revenue Breakdown
| Period Ending | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|
| Grant Revenue | 250K | 250K |
| Grant Revenue Growth | 0.00% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.68M | 1.69M | 1.56M | 1.4M | 1.8M | 1.75M | 1.33M | 1.12M | 1.25M | 883.57K | 1.22M | 1.04M | 1.33M | 1.08M | 847.13K | 1.37M | 1.98M | 1.2M | 1.01M | 808.33K | 1.52M | 898.25K | 852.84K | 1.03M | 980.45K | 1.03M | 1.18M | 1.01M | 795.46K | 597.08K | 925.04K | 791.35K | 865.2K | 932.03K | 1.1M | 920.72K | 994.43K | 1M | 853.92K | 873.63K | 815.47K |
| Selling, General, and Administrative Revenue Growth | -0.33% | +8.47% | +11.36% | -22.12% | +2.41% | +31.65% | +19.43% | -10.68% | +41.39% | -27.28% | +16.34% | -21.57% | +23.55% | +27.22% | -38.18% | -30.67% | +65.20% | +18.46% | +24.95% | -46.79% | +69.12% | +5.32% | -16.85% | +4.62% | -4.90% | -12.91% | +16.98% | +27.22% | +33.23% | -35.45% | +16.89% | -8.54% | -7.17% | -15.41% | +19.68% | -7.41% | -0.57% | +17.13% | -2.26% | +7.13% | n/a |
| Research and Development Revenue | 341.54K | 1.67M | 879.04K | 906.78K | 663.41K | 768.48K | 769.35K | 2.01M | 1.67M | -523.16K | 2.82M | 3.03M | 4.74M | 1.31M | 3.55M | 2.47M | 3.26M | 3.35M | 3.5M | 11.54M | 3.71M | 2.76M | 3.07M | 3.88M | 2.41M | 1.79M | 1.58M | 1.27M | 1.33M | 815.31K | 996.48K | 605.41K | 1.12M | 1.78M | 924.8K | 812.57K | 1.24M | 1.34M | 1.17M | 5.61M | 676.6K |
| Research and Development Revenue Growth | -79.49% | +89.43% | -3.06% | +36.68% | -13.67% | -0.11% | -61.66% | +19.98% | -419.71% | -118.52% | -6.88% | -35.98% | +261.59% | -63.06% | +43.76% | -24.33% | -2.73% | -4.17% | -69.70% | +210.93% | +34.53% | -10.03% | -20.92% | +60.71% | +34.58% | +13.48% | +24.30% | -4.12% | +62.67% | -18.18% | +64.60% | -46.06% | -36.79% | +92.03% | +13.81% | -34.54% | -7.61% | +14.77% | -79.14% | +729.44% | n/a |